Preogem
09-19-2022, 12:52 AM
doxycycline cat ([Only registered and activated users can see links]) 60 With a median follow- up of 35 months, the brentuximab vedotin combination 3- year OS rate, 77 showed an OS advantage over CHOP 3- year OS rate, 68; hazard ratio HR, 0.